Lutetium therapy-induced carcinoid crisis: A case report and review of literature
Peptide receptor radionuclide therapy with lutetium (Lu)-labeled somatostatin analogs is a promising new tool in the management of patients with inoperable or metastatic neuroendocrine tumors. Some of these patients may present with carcinoid syndrome and it is known that rarely carcinoid crisis can...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and therapeutics 2020-12, Vol.16 (Supplement), p.S206-208 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!